Given the demand for Ozempic and Wegovy and the revenue the GLP-1 drugs are generating for Novo Nordisk A/S in the U.S., a lot of generic companies are clamoring to cash in on the drugs’ current ...

Australia is considering whether to prioritise athletes and support staff in the COVID-19 vaccine rollout with the Tokyo Olympics fast approaching.